Literature DB >> 22250891

Anthracyclinones from Micromonospora sp.

Thiciana da S Sousa1, Paula C Jimenez, Elthon G Ferreira, Edilberto R Silveira, Raimundo Braz-Filho, Otília D L Pessoa, Letícia V Costa-Lotufo.   

Abstract

Four new anthracyclinones, 4,6,11-trihydroxy-9-propyltetracene-5,12-dione (1), 1-methoxy-9-propyltetracene-6,11-dione (2), 7,8,9,10-tetrahydro-9-hydroxy-1-methoxy-9-propyltetracene-6,11-dione (3), and 10β-carbomethoxy-7,8,9,10-tetrahydro-4,6,7α,9α,11-pentahydroxy-9-propyltetracene-5,12-dione (4), were isolated from a strain of Micromonospora sp. associated with the tunicate Eudistoma vannamei. All structures were established by 1D and 2D NMR (COSY, HSQC, HMBC, NOESY) and HRESIMS experiments. Compounds 1 and 4 were cytotoxic against the HCT-8 human colon adenocarcinoma cell line, with IC(50) values of 12.7 and 6.2 μM, respectively, while compounds 2 and 3 were inactive.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22250891     DOI: 10.1021/np200795p

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  12 in total

1.  Micromonohalimanes A and B: Antibacterial Halimane-Type Diterpenoids from a Marine Micromonospora Species.

Authors:  Yan Zhang; Navid Adnani; Doug R Braun; Gregory A Ellis; Kenneth J Barns; Shirley Parker-Nance; Ilia A Guzei; Tim S Bugni
Journal:  J Nat Prod       Date:  2016-11-04       Impact factor: 4.050

Review 2.  Antimicrobial aromatic polyketides: a review of their antimicrobial properties and potential use in plant disease control.

Authors:  Jae Woo Han; Gyung Ja Choi; Beom Seok Kim
Journal:  World J Microbiol Biotechnol       Date:  2018-10-28       Impact factor: 3.312

3.  Actinomycetes from the South China Sea sponges: isolation, diversity, and potential for aromatic polyketides discovery.

Authors:  Wei Sun; Fengli Zhang; Liming He; Loganathan Karthik; Zhiyong Li
Journal:  Front Microbiol       Date:  2015-10-01       Impact factor: 5.640

4.  Integration of culture-based and molecular analysis of a complex sponge-associated bacterial community.

Authors:  Naomi F Montalvo; Jeanette Davis; Jan Vicente; Raquel Pittiglio; Jacques Ravel; Russell T Hill
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

Review 5.  Marine Rare Actinobacteria: Isolation, Characterization, and Strategies for Harnessing Bioactive Compounds.

Authors:  Dipesh Dhakal; Anaya Raj Pokhrel; Biplav Shrestha; Jae Kyung Sohng
Journal:  Front Microbiol       Date:  2017-06-15       Impact factor: 5.640

Review 6.  Marine drugs for cancer: surfacing biotechnological innovations from the oceans.

Authors:  Paula Christine Jimenez; Diego Veras Wilke; Leticia Veras Costa-Lotufo
Journal:  Clinics (Sao Paulo)       Date:  2018-08-20       Impact factor: 2.365

Review 7.  Natural Products from Actinomycetes Associated with Marine Organisms.

Authors:  Jianing Chen; Lin Xu; Yanrong Zhou; Bingnan Han
Journal:  Mar Drugs       Date:  2021-11-10       Impact factor: 5.118

8.  Palyosulfonoceramides A and B: unique sulfonylated ceramides from the Brazilian zoanthids Palythoa caribaeorum and Protopalythoa variabilis.

Authors:  Jose Gustavo L Almeida; Ana Isabel V Maia; Diego V Wilke; Edilberto R Silveira; Raimundo Braz-Filho; James J La Clair; Leticia V Costa-Lotufo; Otília Deusdenia L Pessoa
Journal:  Mar Drugs       Date:  2012-12-14       Impact factor: 5.118

Review 9.  From Seabed to Bedside: A Review on Promising Marine Anticancer Compounds.

Authors:  Edina Wang; Maria Alba Sorolla; Priya Darshini Gopal Krishnan; Anabel Sorolla
Journal:  Biomolecules       Date:  2020-02-06

10.  In Vitro Antitumor Activity of Endophytic and Rhizosphere Gram-Positive Bacteria from Ibervillea sonorae (S. Watson) Greene against L5178Y-R Lymphoma Cells.

Authors:  Ricardo Romero-Arguelles; César Iván Romo-Sáenz; Karla Morán-Santibáñez; Patricia Tamez-Guerra; Ramiro Quintanilla-Licea; Alonso Alberto Orozco-Flores; Jesica María Ramírez-Villalobos; Reyes Tamez-Guerra; Cristina Rodríguez-Padilla; Ricardo Gomez-Flores
Journal:  Int J Environ Res Public Health       Date:  2022-01-14       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.